Zhang, Wen
Li, Ming
Zan, Yanlu
Bai, Yi
Article History
Accepted: 16 July 2021
First Online: 11 August 2021
Declarations
:
: Exendin-4-Fc has been developed as a drug (under name JY09) for type 2 diabetes and a Phase II clinical trial (#CTR20192166) is being carried out in China. Interest of Exendin-4-Fc is protected by Patent CN101891823B.
: This study was approved by the Institutional Animal Care and Use Committee at the Animal Center, Beijing Eastern Biotech, Co., Ltd. (ACU11-527).
: Not applicable.